Javascript must be enabled to continue!
Female Pattern Hair Loss and Negative Psychological Impact: Possible Role of Brain-derived Neurotrophic Factor (BDNF)
View through CrossRef
Introduction: Female Pattern Hair Loss (FPHL) is considered the most common type of hair loss in females. Women with FPHL may suffer from psychological distress and defective social functioning. Patients with psychiatric and neurodegenerative disorders almost have a deficient brain and blood brain-derived neurotrophic factor levels (BDNF). This serum BDNF level may act as a diagnostic marker for negative psychological impact in FPHL patients.
Objectives: Evaluate the levels of serum BDNF in patients with FPHL and correlate its level to the severity of alopecia and the degree of psychological impact.
Methods: Forty-six female patients with FPHL and 41 healthy age-matched female volunteers as a control were included in the study. Patients filled out a Dermatology Life Quality Index questionnaire. Both patients and controls filled Beck Depression Inventory, Beck Anxiety Inventory, and Perceived Stress Scale (PSS) questionnaires. Serum levels of BDNF were measured for all the participants using the ELISA technique.
Results: Patients with FPHL had significantly lower levels of BDNF and significantly higher Beck depression inventory score and PSS questionnaire scores. There is a significant negative correlation between serum levels of BDNF and Beck Depression Inventory, Beck Anxiety Inventory, and PSS questionnaire scores.
Conclusions: Patients with FPHL are at a high risk to develop chronic stress and depression. The serum level of BDNF is a good predictor for the assessment of chronic stress and depression in FPHL patients.
Title: Female Pattern Hair Loss and Negative Psychological Impact: Possible Role of Brain-derived Neurotrophic Factor (BDNF)
Description:
Introduction: Female Pattern Hair Loss (FPHL) is considered the most common type of hair loss in females.
Women with FPHL may suffer from psychological distress and defective social functioning.
Patients with psychiatric and neurodegenerative disorders almost have a deficient brain and blood brain-derived neurotrophic factor levels (BDNF).
This serum BDNF level may act as a diagnostic marker for negative psychological impact in FPHL patients.
Objectives: Evaluate the levels of serum BDNF in patients with FPHL and correlate its level to the severity of alopecia and the degree of psychological impact.
Methods: Forty-six female patients with FPHL and 41 healthy age-matched female volunteers as a control were included in the study.
Patients filled out a Dermatology Life Quality Index questionnaire.
Both patients and controls filled Beck Depression Inventory, Beck Anxiety Inventory, and Perceived Stress Scale (PSS) questionnaires.
Serum levels of BDNF were measured for all the participants using the ELISA technique.
Results: Patients with FPHL had significantly lower levels of BDNF and significantly higher Beck depression inventory score and PSS questionnaire scores.
There is a significant negative correlation between serum levels of BDNF and Beck Depression Inventory, Beck Anxiety Inventory, and PSS questionnaire scores.
Conclusions: Patients with FPHL are at a high risk to develop chronic stress and depression.
The serum level of BDNF is a good predictor for the assessment of chronic stress and depression in FPHL patients.
Related Results
Brain Organoids, the Path Forward?
Brain Organoids, the Path Forward?
Photo by Maxim Berg on Unsplash
INTRODUCTION
The brain is one of the most foundational parts of being human, and we are still learning about what makes humans unique. Advancements ...
New insights into Brain-derived Neurotrophic Factor Dual Signaling : imbalance implications in mechanisms of neuroprotection and neurotoxicity
New insights into Brain-derived Neurotrophic Factor Dual Signaling : imbalance implications in mechanisms of neuroprotection and neurotoxicity
Nouveaux aspects dans la double signalisation du "Brain-derived Neurotrophic Factor" : implications d'un déséquilibre dans les mécanismes de neuroprotection et neurotoxicité
...
Chemical-LTP induces confinment of BDNF mRNA under dendritic spines and BDNF protein accumulation inside the spines
Chemical-LTP induces confinment of BDNF mRNA under dendritic spines and BDNF protein accumulation inside the spines
Abstract
The neurotrophin brain-derived neurotrophic factor (BDNF) plays a key role in neuronal development and synaptic plasticity. The discovery that BDNF mRNA ca...
Identification of novel BDNF-specific corticostriatal circuitries
Identification of novel BDNF-specific corticostriatal circuitries
Abstract
BDNF is released from axon terminals originating in the cerebral cortex onto striatal neurons. Here, we characterized BDNF neurons in th...
Brain-derived neurotrophic factor serves as a tumor-trophic factor for lung cancer by controlling cell cycle
Brain-derived neurotrophic factor serves as a tumor-trophic factor for lung cancer by controlling cell cycle
Abstract
Background
The nervous system plays a key role in the lung development, and its dysfunction might be related to the occurrence of lung cancer. In fact, neurotroph...
Brain-derived Neurotrophic Factor Level and Gene Polymorphism as Risk Factors for Depression in Patients with type 2 Diabetes Mellitus- A Case-Controlled Study
Brain-derived Neurotrophic Factor Level and Gene Polymorphism as Risk Factors for Depression in Patients with type 2 Diabetes Mellitus- A Case-Controlled Study
Background:
Diabetes mellitus and depression are comorbidities that can be caused
by each other. Brain-derived neurotrophic factor (BDNF) functions as a neuronal growth factor.
It ...
Distribution of Brain‐Derived Neurotrophic Factor in Rats and Its Changes with Development in the Brain
Distribution of Brain‐Derived Neurotrophic Factor in Rats and Its Changes with Development in the Brain
Abstract: A newly established, sensitive, two‐site enzyme‐immunoassay system for brain‐derived neurotrophic factor (BDNF) is described. Using this system, we investigated the tissu...
Brain-Derived Neurotrophic Factor Secreting Human Mesenchymal Stem Cells Improve Outcomes in Rett Syndrome Mouse Models
Brain-Derived Neurotrophic Factor Secreting Human Mesenchymal Stem Cells Improve Outcomes in Rett Syndrome Mouse Models
Rett syndrome (RTT) is a severe X-linked dominant neurodevelopmental disorder caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene; MeCP2 regulates the expression o...

